<SEC-DOCUMENT>0001354457-23-000365.txt : 20230525
<SEC-HEADER>0001354457-23-000365.hdr.sgml : 20230525
<ACCEPTANCE-DATETIME>20230525163900
ACCESSION NUMBER:		0001354457-23-000365
CONFORMED SUBMISSION TYPE:	25-NSE
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230525
DATE AS OF CHANGE:		20230525
EFFECTIVENESS DATE:		20230525

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ASTRAZENECA PLC
		CENTRAL INDEX KEY:			0000901832
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		25-NSE
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11960
		FILM NUMBER:		23961429

	BUSINESS ADDRESS:	
		STREET 1:		1 FRANCIS CRICK AVENUE
		STREET 2:		CAMBRIDGE BIOMEDICAL CAMPUS
		CITY:			CAMBRIDGE
		STATE:			X0
		ZIP:			CB2 0AA
		BUSINESS PHONE:		011 44 20 7304 5000

	MAIL ADDRESS:	
		STREET 1:		1 FRANCIS CRICK AVENUE
		STREET 2:		CAMBRIDGE BIOMEDICAL CAMPUS
		CITY:			CAMBRIDGE
		STATE:			X0
		ZIP:			CB2 0AA

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZENECA GROUP PLC
		DATE OF NAME CHANGE:	19930422

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nasdaq Stock Market LLC
		CENTRAL INDEX KEY:			0001354457
		IRS NUMBER:				521165937
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		25-NSE

	BUSINESS ADDRESS:	
		STREET 1:		One Liberty Plaza
		CITY:			New York
		STATE:			NY
		ZIP:			10006
		BUSINESS PHONE:		301-978-4144

	MAIL ADDRESS:	
		STREET 1:		Office of General Counsel
		STREET 2:		805 King Farm Blvd.
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	The Nasdaq Stock Market LLC
		DATE OF NAME CHANGE:	20060224
</SEC-HEADER>
<DOCUMENT>
<TYPE>25-NSE
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001354457</cik>
        <entityName>Nasdaq Stock Market LLC</entityName>
    </exchange>

    <issuer>
        <cik>0000901832</cik>
        <entityName>ASTRAZENECA PLC</entityName>
        <fileNumber>001-11960</fileNumber>
        <address>
            <street1>1 Francis Crick Avenue</street1>
            <street2>Cambridge Biomedical Campus</street2>
            <city>Cambridge</city>
            <stateOrCountryCode>X0</stateOrCountryCode>
            <stateOrCountry>UNITED KINGDOM</stateOrCountry>
            <zipCode>CB20AA</zipCode>
        </address>
        <telephoneNumber>+44 (0)7585 983549</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>0.300% Notes due 2023</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(a)(2)</ruleProvision>

    <signatureData>
        <signatureName>Tara Petta</signatureName>
        <signatureTitle>AVP</signatureTitle>
        <signatureDate>2023-05-25</signatureDate>
    </signatureData>
</notificationOfRemoval>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.25
<SEQUENCE>2
<FILENAME>form25.txt
<TEXT>
Form 25
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
